Surgical Infection Control Markets in Europe

Frost & Sullivan
January 23, 2007
147 Pages - SKU: MC1471997
License type:
Countries covered: Europe

This Frost & Sullivan research service titled Surgical Infection Control Markets in Europe provides a comprehensive overview of the markets, along with an analysis of key market drivers and restraints. The study also includes a description of geographic and technology trends that are influencing the surgical infection control markets. In this research, Frost & Sullivan’s expert analysts thoroughly examine the following markets: hand disinfectants, skin and mucous membrane disinfectants, wound disinfectants.

Market Overview

Growing Awareness of Nosocomial Infections Drives Growth in the European Surgical Infection Control Markets

The European surgical infection control markets are highly competitive, mature markets, with growth rates that are modest, yet steady. Rising awareness of nosocomial infections and its multi-level effects on society are the key factors driving growth in these markets. Resulting in increased mortality and morbidity in hospitalised patients, nosocomial infections are becoming a cause of serious concern. As a result, hospitals, healthcare practitioners and government health bodies are focusing on surgical infection control in order to impede and control the spread of nosocomial infections.

"Growth in the European surgical infection control markets is driven by campaigns that are being undertaken to promote awareness of nosocomial infections and their manifold effects," notes the analyst of this research service. "Notably, such awareness campaigns are not limited to the public health sphere, but are reflected across the socio-economic and political spheres of Europe." In addition, the ongoing initiatives to implement pan-European standards in the markets will ensure the standardisation of products and their prices across Europe, thereby assisting market expansion.

Maximisation of Product Efficacy Pivotal for Increased Uptake

The current emphasis on maximising the efficacy of surgical infection control products is a significant factor influencing market growth. Product efficacy is determined by the antimicrobial efficacies, the time taken and the speed with which the antimicrobial activity takes place. Thus, maximising product efficacy, in combination with excellent after-sales services will help assist market participants in distinguishing themselves in the competitive surgical infection control markets.

"Dominated by global and pan-European brands, the surgical infection control markets are saturated," explains the analyst. "Thus, given the dominance of strong Tier I participants, market penetration by smaller companies is difficult to achieve." Moreover, the lack of uniform pan-European regulations makes it harder for smaller companies to license their products across Europe. Hence, in these highly competitive and brand-oriented markets, product differentiation based on technology and efficacy will prove beneficial. Small companies would also do well to collaborate with the major global and European firms in the market, as European standards will level the field of competition in the markets.


More Europe Prescription Drugs Reports

Pharmaceuticals – Poland – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Poland by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...

Switzerland Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: The expected growth of the Switzerland’s ageing population over the next 50 years will havean unprecedented impact on the demand for healthcare. The ...

Spain Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Companies with significant exposure to debt-ridden European markets will be hard hit bygovernment austerity measures across the region, particularly by pharmaceutical price erosionmechanisms. ...

Romania Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Following the resignation of Emil Boc and his government in February 2012, there is nowconsiderable uncertainty with regard to reform of the Romanian ...

Portugal Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measureshave taken their toll on all sectors – including ...

See all reports like this >>

More Europe Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>